Korea Innovation Center Washington DC (KIC DC)’s Post

Turning revolutionary ideas into real-life solutions is the neverending mission of Cedars-Sinai Technology Ventures and the Cedars-Sinai Accelerator. Our organizations, led by Jim Laur, chief intellectual property officer of Cedars-Sinai, and Nirdesh K Gupta, PhD, managing director of Technology Ventures and the Accelerator, constantly evaluate and propel technologies addressing the needs of patients and clinicians worldwide. Want to learn more? Check out the Cedars-Sinai Newsroom interview with Laur and Gupta where they describe how we work with entrepreneurs and their cutting-edge technology to reshape the healthcare industry on a global scale. READ MORE HERE: https://lnkd.in/gC-jtXad #CSaccelerator #healthinnovate #healthaccelerator #HIT #healthdisruptors #CSAclass10

⏰ 59 days to TechCon SoCal! ⏰ We are delighted to introduce Daniel Haders II, Ph.D., the visionary CEO of Model Medicines, as a speaker at TechCon SoCal 2025. With over two decades of innovation in healthcare, Dr. Haders has pioneered the integration of AI into human health, modeling complex chemical and biological systems to develop groundbreaking therapeutics. His leadership at Model Medicines has catalyzed the creation of novel therapies, including the promising MDL-001, backed by prominent investors and supported by over $14 million in funding. Dr. Haders' expertise spans not only scientific research but also digital health entrepreneurship and investment. As the founder of the Nex Cubed Digital Health Accelerator, he has significantly influenced the digital healthcare landscape, fostering a portfolio of over 25 companies valued at more than $250 million. His work in venture capital as an Operating Partner at Sway Ventures, and his strategic roles on various boards, highlight his comprehensive impact on the health tech sector. 🌟 Catch Dr. Daniel Haders at #TechConSoCal2025 to explore the future of AI in healthcare and how it's transforming therapeutic development. A must-attend for anyone interested in the nexus of technology and health! 🚀 📅 January 17-18, 2025 | San Diego Register now 👉 www.techconsocal.com Watch our teaser video to see what’s in store at TechCon SoCal 2025! https://lnkd.in/diacNCYS Tariq Ahmed Serhat Pala Neal Bloom Sufyan Subzwari Jonah Peake 🐺 NuFund Venture Group Interlock Capital OPEN Silicon Valley Orange County OC Startup Council #TechConSoCal2025 #TechConSoCal #IndustryExperts #TechConference #InnovationSummit #TechTalks #Innovation #Technology #Networking #ArtificialIntelligence #DigitalHealth #Robotics #startups #vc #SandDiegoStartup #Founders #ConsumerTech

Are you ready to witness the visionary solutions that are redefining industries as we know them? We are proud to have these innovators with us: 🦋BrainTrip: Leading the charge in brain-wave devices and brain-diagnosis apps with their vertical SaaS platform that's setting new standards in healthcare technology. 🧠 🦋CheMOnitor: Utilising proprietary AI and blood tests to predict chemotherapy effectiveness in lung cancer cases, offering a groundbreaking approach to personalised cancer treatment. 🫁 🦋Neofunction: Redefining oral hygiene through cutting-edge solutions crafted by passionate dental health professionals, pushing the boundaries of dental care and wellness. 🦷 🦋Fabler: Setting a new paradigm in children's content by personalising it with cloned voices of parents, making every bedtime story an unforgettable experience for families. 😴 🦋Bionome Innovation and Technology Ltd.: Pioneering genetic engineering and sustainable bioprocessing to shape the future of nutraceuticals and pharmaceuticals, revolutionising the way we approach healthcare and wellness. 🧬 Get ready to witness these startups make a profound impact on tomorrow's world! 🤜🤛 . #startups #labenaventures #labena #accelerator #acceleratorprogramme #akcelerator #biotech #pharma #healthtech #food #founders #environment #bootcamp #investing #entrepreneurship #preseed #incubator #businessmentorship #cee #centralandeasterneurope #partner #mentor #bootcamp

**What if startups hold the key to revolutionizing clinical development?** In an ever-evolving healthcare landscape, the traditional methodologies of clinical development are transforming at lightning speed, with startups at the forefront of this change. The article "Blueprint for Change: How startups and a CVC are shaping the future of clinical development" uncovers how innovative companies and corporate venture capitalists (CVCs) are redefining the approach towards drug discovery and clinical trials. This shift not only paves new pathways for treatments but also enhances patient outcomes through improved efficiency and responsiveness. Startups today operate under models that prioritize agility, data-driven insights, and cutting-edge technology. By leveraging artificial intelligence, real-world evidence, and novel therapeutic approaches, these nimble entities challenge long-standing paradigms. Meanwhile, CVCs recognize this potential—forming strategic partnerships that align investment with innovation-driven growth in healthcare sectors. The collaboration between startups and large corporations fosters a unique environment where novel ideas can bloom into tangible solutions without being hindered by bureaucratic delays often associated with traditional systems. This synergy is vital; it creates opportunities to diversify portfolios while simultaneously enriching a startup’s resource base through shared expertise in regulatory navigation, market access strategies, and extensive networks within healthcare ecosystems. This dynamic pairing encourages an ecosystem where risk-sharing is paramount—encouraging more bold ventures into uncharted territories such as personalized medicine or decentralized trials. The question arises: how much greater could innovations blossom when corporate giants open their doors wider to these agile newcomers? As stakeholders increasingly acknowledge these transformative changes brought about by collaborations across various sectors within healthcare innovation spaces—including digital health solutions or patient-centric approaches—the critical need emerges for organizations to adapt accordingly. Establishing connections between established firms seeking fresh perspectives on development processes enables cultivation of ground-breaking ideas which might have otherwise been overlooked. Are you ready to drive your own corporate innovation forward? 🚀 Take action today! Connect with startups that can help propel your organization into this exciting future:) Book a meeting here: https://lnkd.in/dFYwmbHq #ClinicalDevelopment #HealthcareInnovation #Startups #CorporateVentureCapital #DrugDiscovery #AIinHealthcare #PatientCentricity #AgileMethodologies #DigitalHealth #BiotechRevolution Dive deeper into how this blueprint is constructed! Read more at https://lnkd.in/dtHwENsW

Are you developing a medical device or digital health? Come learn about regulatory and legal impacts and how design for manufacturing is critical to your startup's success.

**What if startups hold the key to revolutionizing clinical development?** In an ever-evolving healthcare landscape, the traditional methodologies of clinical development are transforming at lightning speed, with startups at the forefront of this change. The article "Blueprint for Change: How startups and a CVC are shaping the future of clinical development" uncovers how innovative companies and corporate venture capitalists (CVCs) are redefining the approach towards drug discovery and clinical trials. This shift not only paves new pathways for treatments but also enhances patient outcomes through improved efficiency and responsiveness. Startups today operate under models that prioritize agility, data-driven insights, and cutting-edge technology. By leveraging artificial intelligence, real-world evidence, and novel therapeutic approaches, these nimble entities challenge long-standing paradigms. Meanwhile, CVCs recognize this potential—forming strategic partnerships that align investment with innovation-driven growth in healthcare sectors. The collaboration between startups and large corporations fosters a unique environment where novel ideas can bloom into tangible solutions without being hindered by bureaucratic delays often associated with traditional systems. This synergy is vital; it creates opportunities to diversify portfolios while simultaneously enriching a startup’s resource base through shared expertise in regulatory navigation, market access strategies, and extensive networks within healthcare ecosystems. This dynamic pairing encourages an ecosystem where risk-sharing is paramount—encouraging more bold ventures into uncharted territories such as personalized medicine or decentralized trials. The question arises: how much greater could innovations blossom when corporate giants open their doors wider to these agile newcomers? As stakeholders increasingly acknowledge these transformative changes brought about by collaborations across various sectors within healthcare innovation spaces—including digital health solutions or patient-centric approaches—the critical need emerges for organizations to adapt accordingly. Establishing connections between established firms seeking fresh perspectives on development processes enables cultivation of ground-breaking ideas which might have otherwise been overlooked. Are you ready to drive your own corporate innovation forward? 🚀 Take action today! Connect with startups that can help propel your organization into this exciting future:) Book a meeting here: https://lnkd.in/dFYwmbHq #ClinicalDevelopment #HealthcareInnovation #Startups #CorporateVentureCapital #DrugDiscovery #AIinHealthcare #PatientCentricity #AgileMethodologies #DigitalHealth #BiotechRevolution Dive deeper into how this blueprint is constructed! Read more at https://lnkd.in/d38mmnTf

𝗖𝗮𝗹𝗹𝗶𝗻𝗴 𝗔𝗹𝗹 𝗠𝗲𝗱𝗶𝗰𝗮𝗹 𝗗𝗲𝘃𝗶𝗰𝗲 & 𝗗𝗶𝗮𝗴𝗻𝗼𝘀𝘁𝗶𝗰𝘀 𝗜𝗻𝗻𝗼𝘃𝗮𝘁𝗼𝗿𝘀! Join us at Aquillius next 𝗪𝗲𝗱𝗻𝗲𝘀𝗱𝗮𝘆, 𝗠𝗮𝘆 𝟭𝟱𝘁𝗵 for the 𝗠𝗲𝗱𝗶𝗰𝗮𝗹 𝗗𝗲𝘃𝗶𝗰𝗲𝘀 𝗮𝗻𝗱 𝗗𝗶𝗮𝗴𝗻𝗼𝘀𝘁𝗶𝗰𝘀 𝗦𝘆𝗺𝗽𝗼𝘀𝗶𝘂𝗺 packed with insights from industry leaders. Learn how to navigate the path to success for your groundbreaking technology. 𝗠𝗲𝗲𝘁 𝗢𝘂𝗿 𝗦𝗽𝗲𝗮𝗸𝗲𝗿𝘀: ⚕ Hiro Nakajima (ASPINA America): "𝗧𝗵𝗲 𝗜𝗺𝗽𝗼𝗿𝘁𝗮𝗻𝗰𝗲 & 𝗖𝗵𝗮𝗹𝗹𝗲𝗻𝗴𝗲𝘀 𝗼𝗳 𝗗𝗲𝘀𝗶𝗴𝗻 𝗳𝗼𝗿 𝗠𝗮𝗻𝘂𝗳𝗮𝗰𝘁𝘂𝗿𝗶𝗻𝗴." Hear how to overcome design obstacles and considerations for successful manufacturing during Aspina's Lunch & Learn. ⚕ Shawnnah Monterrey, MBA (BeanStock Ventures): "𝗨𝗻𝗹𝗼𝗰𝗸𝗶𝗻𝗴 𝗚𝗿𝗼𝘄𝘁𝗵: 𝗥𝗲𝗴𝘂𝗹𝗮𝘁𝗼𝗿𝘆 𝗖𝗼𝗻𝘀𝗶𝗱𝗲𝗿𝗮𝘁𝗶𝗼𝗻𝘀 𝗳𝗼𝗿 𝗠𝗲𝗱𝘁𝗲𝗰𝗵 𝗦𝘁𝗮𝗿𝘁𝘂𝗽 𝗦𝘂𝗰𝗰𝗲𝘀𝘀 𝗮𝗻𝗱 𝗜𝗻𝘃𝗲𝘀𝘁𝗼𝗿 𝗖𝗼𝗻𝗳𝗶𝗱𝗲𝗻𝗰𝗲." Gain valuable insights into the regulatory landscape and its critical role in securing investor confidence and propelling the growth of your medtech startup. ⚕ Noel Gillespie (Procopio, Cory, Hargreaves & Savitch LLP): "𝗣𝗿𝗼𝘁𝗲𝗰𝘁𝗶𝗻𝗴 𝗬𝗼𝘂𝗿 𝗜𝗻𝗻𝗼𝘃𝗮𝘁𝗶𝗼𝗻: 𝗜𝗻𝘁𝗲𝗹𝗹𝗲𝗰𝘁𝘂𝗮𝗹 𝗣𝗿𝗼𝗽𝗲𝗿𝘁𝘆 𝗦𝘁𝗿𝗮𝘁𝗲𝗴𝗶𝗲𝘀 𝗳𝗼𝗿 𝗠𝗲𝗱𝗶𝗰𝗮𝗹 𝗗𝗲𝘃𝗶𝗰𝗲𝘀." Learn how to safeguard your technology through strategic patent development and implementation, securing a competitive edge in the market. ⚕ Wendy Charles, PhD: "𝗗𝗲𝗺𝘆𝘀𝘁𝗶𝗳𝘆𝗶𝗻𝗴 𝘁𝗵𝗲 𝗠𝗮𝘇𝗲: 𝗥𝗲𝗴𝘂𝗹𝗮𝘁𝗶𝗼𝗻𝘀 𝗮𝘀 𝗬𝗼𝘂𝗿 𝗚𝘂𝗶𝗱𝗲 𝘁𝗼 𝗗𝗶𝗴𝗶𝘁𝗮𝗹 𝗛𝗲𝗮𝗹𝘁𝗵 𝗦𝘂𝗰𝗰𝗲𝘀𝘀." Discover how regulations can be leveraged as a roadmap to achieve impactful results in the ever-evolving digital health landscape. 𝗗𝗼𝗻'𝘁 𝗺𝗶𝘀𝘀 𝘁𝗵𝗶𝘀 𝗼𝗽𝗽𝗼𝗿𝘁𝘂𝗻𝗶𝘁𝘆 𝘁𝗼: 🔸Gain expert knowledge from seasoned professionals. 🔸Network with a community of passionate innovators and potential collaborators. 🔸Propel your medical device or diagnostic innovation forward. 𝗟𝗶𝗺𝗶𝘁𝗲𝗱 𝗦𝗽𝗼𝘁𝘀 𝗔𝘃𝗮𝗶𝗹𝗮𝗯𝗹𝗲! 𝗥𝗲𝗴𝗶𝘀𝘁𝗲𝗿 𝗡𝗼𝘄! https://lnkd.in/gPw8B6Ea #medicaldevices #diagnostics #medtech #startups #innovation #Aquillius Aquillius Ventures Startup San Diego StartOut OUTbio San Diego MyPhuong Le, PhD Leah Villegas, PhD, MBA Women In Bio-Southern California California Life Sciences (CLS) Biocom California Biotech Networks

A startup founder in biotech faces the challenge of juggling numerous urgent tasks, making it difficult to prioritize business and scientific goals effectively. At Religaire Bio LLC we collaborate with founders to identify and prioritize goals based on urgency, importance, and feasibility. Our approach goes beyond assisting with drug development roadmaps. We specialize in: - Developing tailored strategies and actionable plans to tackle high-priority areas. - Providing scientific insights to enhance product development, research methodologies, and innovation strategies. - Offering cost-effective solutions. Our flex-pricing model is early-stage startup friendly! - Leveraging our extensive professional network to connect founders with CRO/CDMOs, academic partners, and industry experts. Feel free to reach out if you’d like to connect or discuss about your project! #Biotech #Startup #BusinessGoals #Scientificgoals #Innovation #DrugDevelopment #Strategies

This is BIG news in the digital health startup space. PharmStars is announcing "Rare Disease" as its subject area for the Spring 2025 term AND, PharmStars is offering funding to the startups completing the program. Help me spread the word by forwarding this on to anyone you know in the digital health startup world who is working on rare diseases. PharmStars will will assist in the training and development of senior execs to improve their chances of getting access to and making deals with top pharma companies. If you know of anyone with a rare disease, please forward to them as they are likely aware of who is doing work in their disease area.